Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury

NCT07563296 is registered in ClinicalTrials.gov with Irma Fleming as lead sponsor.

NCT NCT07563296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07563296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury
Lead sponsor
Irma Fleming
Phase
Phase 2
Overall status
Recruiting
Start date
August 24, 2026
Completion date
April 1, 2028
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ptsd and trauma-related symptoms